Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Vaccines
  3. Pneumococcal (Prevnar13)
  4. Respiratory tract congestion
Pneumococcal (Prevnar13)×Respiratory tract congestion

Respiratory tract congestion Reports for Pneumococcal (Prevnar13)

#140 most reported symptom for this vaccine

170
Reports
4
Deaths
45
Hospitalizations
2.35
Mortality Rate
%
26.5
Hosp. Rate
%

Respiratory tract congestion and Pneumococcal (Prevnar13)

Respiratory tract congestion has been reported 170 times in association with Pneumococcal (Prevnar13) vaccination in VAERS. This represents 0.5% of all 33,058 reports for this vaccine.

Among these reports, 4 mentioned death (2.35%) and 45 involved hospitalization (26.5%).

Respiratory tract congestion is the #140 most frequently reported symptom for Pneumococcal (Prevnar13) out of 1920 total symptoms.

Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.

What This Means

Seeing 170 reports of Respiratory tract congestion after Pneumococcal (Prevnar13) vaccination may seem alarming, but context is critical.

The mortality rate of 2.35% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.

Important Context

•Association, not causation: These reports show Respiratory tract congestion occurred after vaccination, not that the vaccine caused it.
•Background rates: Respiratory tract congestion may occur naturally at baseline rates in the population, unrelated to vaccination.
•Anyone can report: VAERS accepts reports from anyone — patients, parents, healthcare providers — without requiring medical verification.
•Denominator missing: VAERS counts reports, not rates per dose. Without knowing how many doses were given, raw counts can be misleading. Learn more →

Similarly Ranked Symptoms

Feeling hot171 reportsBack pain171 reportsResuscitation168 reportsEmotional distress168 reports

Quick Facts

Reports:170
Deaths:4
Hospitalizations:45
% of Vaccine:0.5%
Rank:#140 of 1920

Related Pages

Pneumococcal (Prevnar13) OverviewRespiratory tract congestion (All Vaccines)Why Raw Numbers MisleadTop Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.